FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742267117> ?p ?o ?g. }

• W2742267117 endingPage "951" @default.
• W2742267117 startingPage "940" @default.
• W2742267117 abstract "Patients with COPD have an increased risk of T2DM and, conversely, COPD is a common comorbidity of T2DM. It is important to understand whether COPD comes first followed by T2DM or vice versa, or whether the diseases develop simultaneously on a common pathological substrate; such information will be vital for the development of novel therapeutic approaches that could control or slow down the progress of COPD and T2DM. While increasing evidence suggests that the systemic inflammatory pathway provides the common link between COPD and T2DM, the mechanisms by which the systemic component arises are unclear. Currently, most pharmacological approaches for the management of COPD and T2DM are only symptomatic, and do not tackle the inherent cause of these defects. The most relevant approach to simultaneously treat COPD and T2DM is likely to involve interfering with the common inflammatory substrate. Since the impairment in lung function seen in patients with diabetes can lower the threshold for clinical manifestations of COPD, it is critical to also ensure glycemic control, because high glucose concentrations can lead to the enhanced responsiveness of human airway smooth muscle. Experimental results suggest that the glucagon-like polypeptide 1 receptor (GLP1-R) is a potential novel pharmacological target for the simultaneous treatment of COPD and T2DM. Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often coexist. The mechanistic links between these two diseases are complex, multifactorial, and not entirely understood, but they can influence the approach to treatment. Understanding whether COPD comes first followed by T2DM or vice versa, or whether the two diseases develop simultaneously due to common underlying mechanisms, is important for the development of novel therapeutic approaches to these two important diseases. In this review, we discuss the potential links between COPD and T2DM and pharmacological approaches that might target these links. Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often coexist. The mechanistic links between these two diseases are complex, multifactorial, and not entirely understood, but they can influence the approach to treatment. Understanding whether COPD comes first followed by T2DM or vice versa, or whether the two diseases develop simultaneously due to common underlying mechanisms, is important for the development of novel therapeutic approaches to these two important diseases. In this review, we discuss the potential links between COPD and T2DM and pharmacological approaches that might target these links. the two most-common functional single nucleotide polymorphisms of the ADRB2 are rs1042713 (46GA) and rs1042714 (79CG), which result in changes in amino acids at codon 16 (Arg to Gly) and codon 27 (Gln to Glu), respectively. Various studies have shown that these polymorphisms have broad effects because of their involvement in not only vascular responses but also pulmonary, endocrine, and central nervous systems functioning. The roles of Arg16Gly and Gln27Glu polymorphisms in the pathophysiology of diseases of the heart, hypertension, obesity, diabetes, asthma, Alzheimer disease, COPD, and cancer have been studied in different populations. a member of the immunoglobin superfamily of cell surface receptors found in various cell types, including smooth muscle cells, fibroblasts, macrophages, and epithelium. an umbrella term used to describe progressive lung diseases, including emphysema, chronic bronchitis, refractory (nonreversible) asthma, and some forms of bronchiectasis. These diseases are characterized by increasing breathlessness. the naturally occurring form of exenatide; it has a 53% amino acid sequence overlap with mammalian GLP-1 and is resistant to degradation by DPP-4; it has a longer plasma half-life than GLP-1, which is degraded by DPP-4 with a half-life of <2 min. an incretin hormone mainly produced by intestinal L cells in response to nutrient ingestion increasing glucose-stimulated insulin secretion and reducing glucagon release; these effects are mediated by binding to its specific receptor, GLP1-R. proteins or lipids that become glycated as a result of exposure to sugars. AGEs generate oxidative stress and subsequently cause inflammatory and thrombogenic reactions in various types of cell via interaction with RAGE; thus, they are involved in vascular complications in diabetes. comprise cytosolic pattern-recognition receptors (PRRs), commonly of the Nod-like receptor family [denoted nucleotide-binding domain leucine-rich repeat-containing receptors (NLRs)] and their binding partners. A single cell may express several inflammasome PRRs, each capable of sensing distinct pathogen- or damage-associated ligand(s). Despite differences in ligand specificity, inflammasome PRRs converge with minor exceptions on a common intracellular signaling cascade. Inflammasome signaling impinges the activation of inflammatory caspases (i.e., caspases 1, 4, 5, and 11) and endows host cells with a sentinel system to sense microbial intrusion and thereby initiate appropriate immune responses. drugs that can be taken by mouth to treat hyperglycemia. PI3K and its downstream serine/threonine kinase, Akt, are important signal transduction pathways involved in many cellular processes, including cell cycle progression, proliferation, and survival. PI3K/Akt can be activated by a variety of growth factors, such as insulin, nerve growth factors, and TGF-β1. Activation of the PI3 K/Akt pathway mediates TGF-β1-induced matrix metalloproteinase-13 expression in hepatic stellate cells. Moreover, PI3 K/Akt-dependent NF-κB activation is involved in TGF-β1-induced neuroprotection. the Rho family of GTPases comprises small signaling G proteins that regulate the actin cytoskeleton and cell migration and proliferation. Downstream effectors of Rho include Rho-associated coiled-coil kinases, including the isoforms ROCK1 and ROCK2. The roles of ROCK proteins in cell–cell adhesion and cell migration, differentiation, apoptosis, proliferation, and other functions have been extensively studied in epithelial cells from many tissues. a cell signaling protein related to systemic inflammation and a cytokine that institutes the acute phase reaction. Its primary role is in immune cell regulation and it is able to accelerate the release and synthesis of inflammatory cytokines. also called noninsulin-dependent diabetes or adult-onset diabetes; refers to a pathologic condition that occurs commonly in humans and some animals. It involves the chronic elevation of blood glucose and, over time, the development of secondary complications that adversely affect the function of many tissues and organs throughout the body." @default.
• W2742267117 created "2017-08-17" @default.
• W2742267117 creator A5035810516 @default.
• W2742267117 creator A5040626995 @default.
• W2742267117 creator A5053217610 @default.
• W2742267117 creator A5054982987 @default.
• W2742267117 creator A5060089859 @default.
• W2742267117 creator A5062907116 @default.
• W2742267117 date "2017-10-01" @default.
• W2742267117 modified "2023-10-16" @default.
• W2742267117 title "Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus" @default.
• W2742267117 cites W1533778228 @default.
• W2742267117 cites W1581720771 @default.
• W2742267117 cites W1583842385 @default.
• W2742267117 cites W1806654808 @default.
• W2742267117 cites W1969806217 @default.
• W2742267117 cites W1970161046 @default.
• W2742267117 cites W1974373780 @default.
• W2742267117 cites W1981227705 @default.
• W2742267117 cites W1983962433 @default.
• W2742267117 cites W1995276887 @default.
• W2742267117 cites W1996189760 @default.
• W2742267117 cites W2001244779 @default.
• W2742267117 cites W2003757683 @default.
• W2742267117 cites W2007098675 @default.
• W2742267117 cites W2015478670 @default.
• W2742267117 cites W2022903284 @default.
• W2742267117 cites W2026649387 @default.
• W2742267117 cites W2032560941 @default.
• W2742267117 cites W2038009587 @default.
• W2742267117 cites W2057513691 @default.
• W2742267117 cites W2064483915 @default.
• W2742267117 cites W2064938750 @default.
• W2742267117 cites W2076846909 @default.
• W2742267117 cites W2082622955 @default.
• W2742267117 cites W2083668719 @default.
• W2742267117 cites W2089473717 @default.
• W2742267117 cites W2099529067 @default.
• W2742267117 cites W2104399201 @default.
• W2742267117 cites W2106601190 @default.
• W2742267117 cites W2111720094 @default.
• W2742267117 cites W2112673662 @default.
• W2742267117 cites W2114412338 @default.
• W2742267117 cites W2119588296 @default.
• W2742267117 cites W2129358916 @default.
• W2742267117 cites W2130465252 @default.
• W2742267117 cites W2130509783 @default.
• W2742267117 cites W2130905430 @default.
• W2742267117 cites W2134160513 @default.
• W2742267117 cites W2140668162 @default.
• W2742267117 cites W2144283177 @default.
• W2742267117 cites W2147792699 @default.
• W2742267117 cites W2149602039 @default.
• W2742267117 cites W2149951188 @default.
• W2742267117 cites W2150702412 @default.
• W2742267117 cites W2151388121 @default.
• W2742267117 cites W2151491827 @default.
• W2742267117 cites W2154497821 @default.
• W2742267117 cites W2161877876 @default.
• W2742267117 cites W2162633131 @default.
• W2742267117 cites W2162980141 @default.
• W2742267117 cites W2163351331 @default.
• W2742267117 cites W2163401630 @default.
• W2742267117 cites W2167362045 @default.
• W2742267117 cites W2169274492 @default.
• W2742267117 cites W2183021619 @default.
• W2742267117 cites W2205218331 @default.
• W2742267117 cites W2282541787 @default.
• W2742267117 cites W2307692029 @default.
• W2742267117 cites W2325466744 @default.
• W2742267117 cites W2372367909 @default.
• W2742267117 cites W2401306489 @default.
• W2742267117 cites W2411826498 @default.
• W2742267117 cites W2411945721 @default.
• W2742267117 cites W2479201778 @default.
• W2742267117 cites W2508357902 @default.
• W2742267117 cites W2521957162 @default.
• W2742267117 cites W2566339940 @default.
• W2742267117 cites W2585622903 @default.
• W2742267117 cites W2644783328 @default.
• W2742267117 cites W4211217520 @default.
• W2742267117 cites W4293084779 @default.
• W2742267117 cites W55232514 @default.
• W2742267117 doi "https://doi.org/10.1016/j.tips.2017.07.003" @default.
• W2742267117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28784329" @default.
• W2742267117 hasPublicationYear "2017" @default.
• W2742267117 type Work @default.
• W2742267117 sameAs 2742267117 @default.
• W2742267117 citedByCount "37" @default.
• W2742267117 countsByYear W27422671172017 @default.
• W2742267117 countsByYear W27422671172018 @default.
• W2742267117 countsByYear W27422671172019 @default.
• W2742267117 countsByYear W27422671172020 @default.
• W2742267117 countsByYear W27422671172021 @default.
• W2742267117 countsByYear W27422671172022 @default.
• W2742267117 countsByYear W27422671172023 @default.
• W2742267117 crossrefType "journal-article" @default.
• W2742267117 hasAuthorship W2742267117A5035810516 @default.

• next